GSK
Price
$47.03
Change
-$0.15 (-0.32%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
98.58B
26 days until earnings call
Intraday BUY SELL Signals
GSKH
Price
$66.87
Change
-$0.50 (-0.74%)
Updated
Oct 2, 12:30 PM (EDT)
Net Assets
699.38K
Intraday BUY SELL Signals
Interact to see
Advertisement

GSK vs GSKH

GSK vs GSKH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GSK vs. GSKH commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSK is a Buy and GSKH is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
52
SMR RATING
1..100
34
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
55
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GSKGSKH
RSI
ODDS (%)
Bullish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 16 days ago
64%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (GSK: $47.18)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GSK’s FA Score shows that 1 FA rating(s) are green while .

  • GSK’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GSK’s TA Score shows that 4 TA indicator(s) are bullish.

  • GSK’s TA Score: 4 bullish, 7 bearish.

Price Growth

GSK (@Pharmaceuticals: Major) experienced а -4.97% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -3.39%. For the same industry, the average monthly price growth was -8.55%, and the average quarterly price growth was +8.33%.

Reported Earning Dates

GSK is expected to report earnings on Oct 28, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-3.39% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
GSK
Daily Signal:
Gain/Loss:
GSKH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBDC8.700.08
+0.93%
Barings BDC
MINE2.730.01
+0.37%
Mayfair Gold Corp
STM53.500.14
+0.26%
STMicroelectronics NV
KBR35.05-0.11
-0.31%
KBR
TURB1.08-0.05
-4.42%
Turbo Energy SA

GSK and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
-2.06%
NVS - GSK
64%
Loosely correlated
-1.07%
BMY - GSK
54%
Loosely correlated
-1.51%
AMGN - GSK
53%
Loosely correlated
-3.38%
MRK - GSK
53%
Loosely correlated
-1.03%
JNJ - GSK
50%
Loosely correlated
-2.30%
More

GSKH and

Correlation & Price change

A.I.dvisor tells us that GSKH and GSK have been poorly correlated (+-4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GSKH and GSK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSKH
1D Price
Change %
GSKH100%
-1.77%
GSK - GSKH
-4%
Poorly correlated
-2.06%